Q4 2024 Earnings Summary
Metric | YoY Change | Reason |
---|---|---|
Total Revenue | Increased by 66% (from $116,176K to $192,767K) | The dramatic increase in revenue reflects an expanded market presence and higher demand, indicating successful efforts to boost sales compared to Q4 2023. The impressive growth, supported by solid external market conditions and potentially new product initiatives, underscores a robust revenue engine. |
Operating Income | Worsened from a loss of $11,787K to a loss of $51,408K | Despite revenue growth, operating losses deepened significantly, suggesting that rising operating expenses, increased overhead, or other cost pressures have eroded profitability relative to the previous period. This deterioration points to challenges in managing operating costs even as top-line performance improved. |
Net Income | Declined sharply from –$8,981K to –$53,111K | The substantial decline in net income mirrors the worsening operating losses, with additional non-operating expenses or inefficiencies further impacting profitability when compared against the more modest losses of Q4 2023. This indicates that the increased revenue was not sufficient to offset the enlarged cost base and other financial challenges. |
EPS | Fell from –$0.24 to –$1.43 | EPS deteriorated considerably, driven by the enlarged operating and net losses seen in Q4 2024 compared to Q4 2023. This stark drop underscores the adverse impact of increased expenses on per-share earnings, despite the impressive revenue growth. |
Gross Margin | Improved from approximately 70% to about 79.5% | Gross margin improved markedly due to controlled cost of goods sold and enhanced production efficiency, even with higher revenue levels. This improvement suggests better cost management at the manufacturing level, although it was ultimately unable to overcome the overall increase in operating expenses. |
Metric | Period | Guidance | Actual | Performance |
---|---|---|---|---|
Full Year 2024 Worldwide Revenue | FY 2024 | $400M to $405M | $495.7M (sum of Q1: $101.9M, Q2: $104.2M, Q3: $96.9M, Q4: $192.8M) | Beat |
Full Year 2024 Gross Margin | FY 2024 | 66% to 68% | ~72% (derived from total 2024 Revenue: $495.7M − total 2024 COGS: $139.0M (Q1: $30.4M, Q2: $36.7M, Q3: $32.3M, Q4: $39.6M) → ($495.7M−$139.0M)/$495.7M ≈ 72%) | Beat |
Full Year 2024 Operating Expenses | FY 2024 | ~$369.1M | ~$361.3M (sum of Q1 SG&A+R&D: $103.2M, Q2: $90.9M, Q3: $79.1M, Q4: $88.2M) | Beat |
Full Year 2024 Adjusted EBITDA | FY 2024 | Negative $18M to negative $16M | Approx. -$118M (operating income Q1: -$35.8M, Q2: -$25.1M, Q3: -$13.9M, Q4: -$51.4M, plus D&A; no official “Adjusted” figure provided, so this is an approximation) | Missed |